Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 11131 | 1006 | 32.3 | 47% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
| 878 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 11463 |
| 11131 | 1 | COLLATERAL CORONARY FLOW//BETA BLOCKERS//METOPROLOL | 1006 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | COLLATERAL CORONARY FLOW | authKW | 60703 | 0% | 100% | 2 |
| 2 | BETA BLOCKERS | authKW | 60585 | 8% | 3% | 80 |
| 3 | METOPROLOL | authKW | 41936 | 3% | 4% | 33 |
| 4 | HOSP UNIV QUIRON | address | 34142 | 0% | 38% | 3 |
| 5 | ALPHA BETA ADRENERGIC BLOCKADE | authKW | 30352 | 0% | 100% | 1 |
| 6 | AMBULANCE DALARNA CTY | address | 30352 | 0% | 100% | 1 |
| 7 | AMBULANCE GOTEBORG | address | 30352 | 0% | 100% | 1 |
| 8 | AMBULANCE KUNGALV | address | 30352 | 0% | 100% | 1 |
| 9 | AMBULANCE OREBRO | address | 30352 | 0% | 100% | 1 |
| 10 | ANCILLARY PROPERTIES | authKW | 30352 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 14919 | 48% | 0% | 480 |
| 2 | Medicine, General & Internal | 2456 | 24% | 0% | 238 |
| 3 | Pharmacology & Pharmacy | 1374 | 23% | 0% | 234 |
| 4 | Peripheral Vascular Diseases | 747 | 9% | 0% | 87 |
| 5 | Medicine, Research & Experimental | 87 | 5% | 0% | 47 |
| 6 | Geriatrics & Gerontology | 23 | 1% | 0% | 11 |
| 7 | Emergency Medicine | 21 | 1% | 0% | 8 |
| 8 | Toxicology | 18 | 2% | 0% | 21 |
| 9 | BIOLOGY, MISCELLANEOUS | 18 | 0% | 0% | 1 |
| 10 | Theater | 2 | 0% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HOSP UNIV QUIRON | 34142 | 0% | 38% | 3 |
| 2 | AMBULANCE DALARNA CTY | 30352 | 0% | 100% | 1 |
| 3 | AMBULANCE GOTEBORG | 30352 | 0% | 100% | 1 |
| 4 | AMBULANCE KUNGALV | 30352 | 0% | 100% | 1 |
| 5 | AMBULANCE OREBRO | 30352 | 0% | 100% | 1 |
| 6 | HENRY FORD HEART VASC CARDIOL | 30352 | 0% | 100% | 1 |
| 7 | HOSP PHARM MED CARDIOL B | 30352 | 0% | 100% | 1 |
| 8 | HP DIAGNOST THER EUT | 30352 | 0% | 100% | 1 |
| 9 | KLINIKUM MANNHEIM GGMBH KLIN PHARMAKOL | 30352 | 0% | 100% | 1 |
| 10 | MARINE SCI ARCT BIOL | 30352 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ACTA MEDICA SCANDINAVICA | 17867 | 3% | 2% | 35 |
| 2 | EUROPEAN HEART JOURNAL | 8401 | 5% | 1% | 53 |
| 3 | CARDIOLOGY | 7271 | 3% | 1% | 28 |
| 4 | AMERICAN JOURNAL OF CARDIOLOGY | 6018 | 7% | 0% | 73 |
| 5 | AMERICAN HEART JOURNAL | 3344 | 4% | 0% | 40 |
| 6 | ANNALS OF CLINICAL RESEARCH | 3254 | 1% | 1% | 8 |
| 7 | CLINICAL CARDIOLOGY | 3239 | 2% | 0% | 22 |
| 8 | JOURNAL OF CLINICAL AND HOSPITAL PHARMACY | 3013 | 0% | 2% | 5 |
| 9 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2441 | 3% | 0% | 30 |
| 10 | JOURNAL OF CLINICAL PHARMACOLOGY | 2205 | 2% | 0% | 20 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | COLLATERAL CORONARY FLOW | 60703 | 0% | 100% | 2 | Search COLLATERAL+CORONARY+FLOW | Search COLLATERAL+CORONARY+FLOW |
| 2 | BETA BLOCKERS | 60585 | 8% | 3% | 80 | Search BETA+BLOCKERS | Search BETA+BLOCKERS |
| 3 | METOPROLOL | 41936 | 3% | 4% | 33 | Search METOPROLOL | Search METOPROLOL |
| 4 | ALPHA BETA ADRENERGIC BLOCKADE | 30352 | 0% | 100% | 1 | Search ALPHA+BETA+ADRENERGIC+BLOCKADE | Search ALPHA+BETA+ADRENERGIC+BLOCKADE |
| 5 | ANCILLARY PROPERTIES | 30352 | 0% | 100% | 1 | Search ANCILLARY+PROPERTIES | Search ANCILLARY+PROPERTIES |
| 6 | BETA BLOCKER PROPERTIES | 30352 | 0% | 100% | 1 | Search BETA+BLOCKER+PROPERTIES | Search BETA+BLOCKER+PROPERTIES |
| 7 | BETA1 SELECTIVE | 30352 | 0% | 100% | 1 | Search BETA1+SELECTIVE | Search BETA1+SELECTIVE |
| 8 | CAPRICORN TRIAL | 30352 | 0% | 100% | 1 | Search CAPRICORN+TRIAL | Search CAPRICORN+TRIAL |
| 9 | CARDIOLOGY NURSING | 30352 | 0% | 100% | 1 | Search CARDIOLOGY+NURSING | Search CARDIOLOGY+NURSING |
| 10 | CARDIOVASCULAR TRIALS | 30352 | 0% | 100% | 1 | Search CARDIOVASCULAR+TRIALS | Search CARDIOVASCULAR+TRIALS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | YUSUF, S , PETO, R , LEWIS, J , COLLINS, R , SLEIGHT, P , (1985) BETA-BLOCKADE DURING AND AFTER MYOCARDIAL-INFARCTION - AN OVERVIEW OF THE RANDOMIZED TRIALS.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 27. ISSUE 5. P. 335-371 | 29 | 81% | 2167 |
| 2 | FREEMANTLE, N , CLELAND, J , YOUNG, P , MASON, J , HARRISON, J , (1999) BETA BLOCKADE AFTER MYOCARDIAL INFARCTION: SYSTEMATIC REVIEW AND META REGRESSION ANALYSIS.BRITISH MEDICAL JOURNAL. VOL. 318. ISSUE 7200. P. 1730 -1737 | 30 | 68% | 718 |
| 3 | BANGALORE, S , MAKANI, H , RADFORD, M , THAKUR, K , TOKLU, B , KATZ, SD , DINICOLANTONIO, JJ , DEVEREAUX, PJ , ALEXANDER, KP , WETTERSLEV, J , ET AL (2014) CLINICAL OUTCOMES WITH BETA-BLOCKERS FOR MYOCARDIAL INFARCTION: A META-ANALYSIS OF RANDOMIZED TRIALS.AMERICAN JOURNAL OF MEDICINE. VOL. 127. ISSUE 10. P. 939 -953 | 28 | 56% | 39 |
| 4 | CHATTERJEE, S , CHAUDHURI, D , VEDANTHAN, R , FUSTER, V , IBANEZ, B , BANGALORE, S , MUKHERJEE, D , (2013) EARLY INTRAVENOUS BETA-BLOCKERS IN PATIENTS WITH ACUTE CORONARY SYNDROME-A META-ANALYSIS OF RANDOMIZED TRIALS.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 168. ISSUE 2. P. 915-921 | 20 | 87% | 14 |
| 5 | SORIANO, JB , HOES, AW , MEEMS, L , GROBBEE, DE , (1997) INCREASED SURVIVAL WITH BETA-BLOCKERS: IMPORTANCE OF ANCILLARY PROPERTIES.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 39. ISSUE 5. P. 445-456 | 39 | 67% | 60 |
| 6 | RAPOSEIRAS-ROUBIN, S , ABU-ASSI, E , REDONDO-DIEGUEZ, A , GONZALEZ-FERREIRO, R , LOPEZ-LOPEZ, A , BOUZAS-CRUZ, N , CASTINEIRA-BUSTO, M , GIL, CP , GARCIA-ACUNA, JM , GONZALEZ-JUANATEY, JR , (2015) PROGNOSTIC BENEFIT OF BETA-BLOCKERS AFTER ACUTE CORONARY SYNDROME WITH PRESERVED SYSTOLIC FUNCTION. STILL RELEVANT TODAY?.REVISTA ESPANOLA DE CARDIOLOGIA. VOL. 68. ISSUE 7. P. 585 -591 | 21 | 78% | 2 |
| 7 | PLOSKER, GL , CLISSOLD, SP , (1992) CONTROLLED RELEASE METOPROLOL FORMULATIONS - A REVIEW OF THEIR PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND ISCHEMIC-HEART-DISEASE.DRUGS. VOL. 43. ISSUE 3. P. 382-414 | 57 | 48% | 29 |
| 8 | MISUMIDA, N , HARJAI, K , KERNIS, S , KANEI, Y , (2016) DOES ORAL BETA-BLOCKER THERAPY IMPROVE LONG-TERM SURVIVAL IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WITH PRESERVED SYSTOLIC FUNCTION? A META-ANALYSIS.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 21. ISSUE 3. P. 280 -285 | 16 | 76% | 1 |
| 9 | WIKSTRAND, J , BERGLUND, G , TUOMILEHTO, J , (1991) BETA-BLOCKADE IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE IN HYPERTENSIVE PATIENTS - REVIEW OF PRESENT EVIDENCE.CIRCULATION. VOL. 84. ISSUE 6. P. 93-100 | 37 | 73% | 9 |
| 10 | KENDALL, MJ , MAXWELL, SRJ , SANDBERG, A , WESTERGREN, G , (1991) CONTROLLED RELEASE METOPROLOL - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS.CLINICAL PHARMACOKINETICS. VOL. 21. ISSUE 5. P. 319-330 | 36 | 71% | 26 |
Classes with closest relation at Level 1 |